Breast cancer screening should begin at age 40, U.S. panel says
By Amina Niasse NEW YORK (Reuters) - Women at average risk for breast cancer should get screening mammograms every other year...
6h ago
Incyte misses quarterly profit on weak sales of lead drug
(Reuters) - Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cance...
8h ago
GE HealthCare misses quarterly revenue estimates on weakness in China market
(Reuters) - GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market...
9h ago
Ecolab to sell global surgical unit for $950 million, lifts 2024 profit forecast
(Reuters) - Water solutions company Ecolab said on Tuesday it would sell its global surgical solutions business to private me...
10h ago
Walmart to close 51 US health centers
(Reuters) - Walmart said on Tuesday it plans to close 51 health centers across five states in the U.S., as well as shut virtu...
11h ago
Eli Lilly lifts profit view on diabetes and weight-loss drug strength
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment...
11h ago
Risk of bird flu spreading to cows outside US, says WHO
GENEVA (Reuters) - A World Health Organization official said on Tuesday there was a risk of H5N1 bird flu virus spreading to ...
12h ago
Japan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansion
By Rocky Swift TOKYO (Reuters) - Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmac...
14h ago
Sandoz reaches agreement with Amgen over patent dispute
ZURICH (Reuters) - Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. dru...
15h ago
Australian regulator weighs India spice mix issue for possible recall
By Rishika Sadam and Aditya Kalra HYDERABAD/NEW DELHI (Reuters) - Australia's food safety agency said on Tuesday it was weigh...
18h ago